Stock JUNO THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Juno Therapeutics Inc

Equities

US48205A1097

Biotechnology & Medical Research

Managers

Managers TitleAgeSince
Nicole Keith IRC
 Investor Relations Contact - 30/06/15
Jonathan Biller TRE
 Treasurer 61 -
Katherine Reynolds Kelly SEC
 Corporate Secretary 48 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 116,105,371 90,604,961 ( 78.04 %) 0 78.04 %

Company contact information

Juno Therapeutics, Inc.

400 Dexter Avenue North Suite 1200

98109, Seattle

+206-582-1600

http://junotherapeutics.com
address Juno Therapeutics Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+15.20% 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+19.67% 113B
ARGENX SE Stock argenx SE
+18.95% 26.02B
BIONTECH SE Stock BioNTech SE
-23.86% 19.39B
GENMAB A/S Stock Genmab A/S
-19.03% 15.91B
BEIGENE, LTD. Stock BeiGene, Ltd.
-20.90% 15.09B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-46.14% 15.06B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+63.85% 14.93B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.49% 13.85B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Juno Therapeutics Inc